| Literature DB >> 31885697 |
Wei Wei1,2, Wenya Bai1,3, Yanchao Yang1, Yang Li1, Xiufei Teng1, Yuxiao Wan1, Junchao Zhu1.
Abstract
Laparoscopy is performed worldwide due to its limited side effects and optimal treatment efficacy. However, it also has adverse effects, including atelectasis and ischemia-reperfusion injury, due to CO2 accumulation during ventilation in a head-down position, which may result in severe disorders and adversely affecting postoperative recovery, prolonging hospitalization. The present study was performed to assess whether transcutaneous electrical acupoint stimulation (TEAS) protects against lung injury occurring during gynecological laparoscopic surgery. Patients were randomly allocated to two groups: Control group (received no stimulation) and TEAS group (patients treated with TEAS on BL13, LI4 and LU5). The mean arterial pressure, heart rate and oxygen saturation were recorded at the time-points of arriving in the operating room (T0), immediately prior to induction of the pneumoperitoneum (T1), immediately after the end of pneumoperitoneum (T2) and on leaving the operating room (T3). Arterial blood gas analysis was performed to record the pH, determine the partial pressure of carbon dioxide and calculate the oxygenation index (OI) at T0-3. Blood samples were taken from the peripheral vein for determination of the serum concentrations of tumor necrosis factor (TNF)-α and interleukin (IL)-1β at T0 and T3. Post-operative pulmonary complications occurring during the first five days after surgery were also recorded. A total of 100 patients were initially enrolled and 80 patients were analysed. The results indicated that the OI in the control group was significantly lower than that in the TEAS group at the T2 and T3 time-points. The serum concentrations of TNF-α and IL-1β were significantly increased following surgery, while the extent of these increases was lower in the TEAS group compared with that in the control group. The incidence of post-operative pulmonary complications was significantly lower in the TEAS group. It was therefore indicated that TEAS protect against lung injury as a complication of gynecological laparoscopic surgery. The present study was registered at http://www.clinicaltrials.gov prior to enrollment of the patients (no. NCT02850471). Copyright: © Wei et al.Entities:
Keywords: gynecologic laparoscopic surgery; oxygen index; post-operative pulmonary complications; pulmonary protection; transcutaneous electric acupoint stimulation
Year: 2019 PMID: 31885697 PMCID: PMC6913376 DOI: 10.3892/etm.2019.8245
Source DB: PubMed Journal: Exp Ther Med ISSN: 1792-0981 Impact factor: 2.447
Figure 1.Flowchart depicting the movement of patients throughout the present study. TEAS, transcutaneous electrical acupoint stimulation.
Comparison of patient characteristics.
| Item | TEAS group (n=41) | Control group (n=39) | P-value |
|---|---|---|---|
| Age (years) | 44.7±10.8 | 47.3±11.0 | 0.303 |
| Body weight (kg) | 55.1±5.4 | 57.0±6.1 | 0.148 |
| Body height (cm) | 160.2±3.9 | 159.9±3.8 | 0.792 |
| Duration of anaesthesia (min) | 157.2±41.2 | 168.1±51.6 | 0.300 |
| Duration of surgery (min) | 140.1±39.4 | 149.3±49.3 | 0.364 |
| Surgery type | |||
| Total hysterectomy | 9 (22.0) | 9 (23.1) | 0.904 |
| Subtotal hysterectomy | 3 (7.3) | 1 (2.6) | 0.616 |
| Total hysterectomy and bilateral appendectomy | 3 (7.3) | 4 (10.3) | 0.709 |
| Myomectomy | 12 (29.3) | 7 (17.9) | 0.234 |
| Oophorocystectomy | 12 (29.3) | 13 (33.3) | 0.695 |
| Radical hysterectomy | 0 (0) | 1 (2.6) | 0.488 |
| Radical hysterectomy and pelvic lymphadenectomy | 2 (4.9) | 4 (10.3) | 0.426 |
Values are expressed as the mean ± standard deviation or n (%). TEAS, transcutaneous electric acupoint stimulation.
Comparison of the variables measured at different time-points.
| Parameters | TEAS group (n=41) | Control group (n=39) |
|---|---|---|
| MAP (mmHg) | ||
| T0 | 89.7±7.9 | 90.7±10.6 |
| T1 | 86.2±9.6 | 86.2±10.8 |
| T2 | 83.1±10.9 | 86.2±10.7 |
| T3 | 86.2±10.1 | 86.1±10.1 |
| HR (beats/min) | ||
| T0 | 76.1±10.7 | 74.7±12.7 |
| T1 | 74.2±10.8 | 69.4±11.7 |
| T2 | 69.8±9.7 | 70.1±11.2 |
| T3 | 73.7±10.5 | 78.3±9.8 |
| SpO2 | ||
| T0 | 99.4±0.6 | 99.5±0.5 |
| T1 | 99.6±0.6 | 99.5±0.7 |
| T2 | 99.6±0.5 | 99.5±0.9 |
| T3 | 99.7±0.8 | 99.6±0.9 |
| pH | ||
| T0 | 7.4±0.04 | 7.4±0.06 |
| T1 | 7.3±0.06 | 7.3±0.04 |
| T2 | 7.3±0.06 | 7.3±0.03 |
| T3 | 7.4±0.03 | 7.4±0.04 |
| PCO2 (mmHg) | ||
| T0 | 42.8±6.1 | 44.4±6.8 |
| T1 | 44.4±8.8 | 45.0±8.1 |
| T2 | 42.1±8.1 | 45.2±7.6 |
| T3 | 39.5±4.9 | 39.9±5.9 |
| OI | ||
| T0 | 425.6±21.2 | 423.2±22.0 |
| T1 | 450.5±30.0 | 442.3±28.9 |
| T2 | 491.6±37.8[ | 460.1±39.3 |
| T3 | 423.7±25.3[ | 395.0±31.5 |
Values are expressed as the mean ± standard deviation.
P<0.05 compared with the patients in the Control group. TEAS, transcutaneous electric acupoint stimulation; MAP, mean arterial pressure; HR, heart rate; OI, oxygen index; PCO2, partial pressure of carbon dioxide; T0, time-point of arriving at the operating room; T1, time-point immediately prior to inducing the pneumoperitoneum; T2, time-point immediately after the end of pneumoperitoneum; T3, on leaving the operating room.
Figure 2.Comparison of the serum concentrations of TNF-α and IL-1β. #P<0.05 compared with the time-point of T0. *P<0.05 compared with patients in the Control group. TEAS, transcutaneous electric acupoint stimulation; TNF-α, tumor necrosis factor-α; IL-1β, interleukin-1β; T0, time-point of arriving at the operating room; T3, leaving the operating room.
Post-operative pulmonary complications in the first five days after surgery.
| Item | TEAS group (n=41) | Control group (n=39) |
|---|---|---|
| Total | 3 (7.3)[ | 10 (25.6) |
| Hypoxaemia | 0 (0)[ | 4 (10.3) |
| Bronchospasm | 0 (0) | 0 (0) |
| Suspected pulmonary infection | 1 (2.4) | 1 (2.6) |
| Pulmonary infiltrate | 0 (0) | 2 (5.1) |
| Aspiration pneumonitis | 0 (0) | 0 (0) |
| Atelectasis | 1 (2.4) | 1 (2.6) |
| Pleural effusion | 1 (2.4) | 2 (5.1) |
| Pulmonary edema | 0 (0) | 0 (0) |
| Pneumothorax | 0 (0) | 0 (0) |
Values are expressed as n (%).
P<0.05 compared with the patients in the Control group. TEAS, transcutaneous electric acupoint stimulation.